COMPREHENSIVE HEALTHCARE SYS (CHS.CA) Fundamental Analysis & Valuation

TSX-V:CHS • CA2046632071

Current stock price

0.59 CAD
0 (0%)
Last:

This CHS.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CHS.CA Profitability Analysis

1.1 Basic Checks

  • In the past year CHS has reported negative net income.
  • CHS had a negative operating cash flow in the past year.
CHS.CA Yearly Net Income VS EBIT VS OCF VS FCFCHS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -1M -2M -3M -4M -5M

1.2 Ratios

  • The Return On Assets of CHS (-127.36%) is worse than 60.00% of its industry peers.
Industry RankSector Rank
ROA -127.36%
ROE N/A
ROIC N/A
ROA(3y)-235.23%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CHS.CA Yearly ROA, ROE, ROICCHS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 -200 -400 -600 -800

1.3 Margins

  • The Gross Margin of CHS (60.93%) is better than 70.00% of its industry peers.
  • In the last couple of years the Gross Margin of CHS has grown nicely.
  • The Profit Margin and Operating Margin are not available for CHS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.64%
GM growth 5YN/A
CHS.CA Yearly Profit, Operating, Gross MarginsCHS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. CHS.CA Health Analysis

2.1 Basic Checks

  • CHS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CHS has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for CHS is higher compared to a year ago.
CHS.CA Yearly Shares OutstandingCHS.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M
CHS.CA Yearly Total Debt VS Total AssetsCHS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M 4M

2.2 Solvency

  • CHS has an Altman-Z score of -38.66. This is a bad value and indicates that CHS is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CHS (-38.66) is worse than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -38.66
ROIC/WACCN/A
WACC9.23%
CHS.CA Yearly LT Debt VS Equity VS FCFCHS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 -2M -4M -6M

2.3 Liquidity

  • A Current Ratio of 0.06 indicates that CHS may have some problems paying its short term obligations.
  • CHS's Current ratio of 0.06 is on the low side compared to the rest of the industry. CHS is outperformed by 90.00% of its industry peers.
  • A Quick Ratio of 0.06 indicates that CHS may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.06, CHS is doing worse than 90.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
CHS.CA Yearly Current Assets VS Current LiabilitesCHS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CHS.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 83.03% over the past year.
  • Looking at the last year, CHS shows a decrease in Revenue. The Revenue has decreased by -1.73% in the last year.
  • CHS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.71% yearly.
EPS 1Y (TTM)83.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114%
Revenue 1Y (TTM)-1.73%
Revenue growth 3Y-5.71%
Revenue growth 5YN/A
Sales Q2Q%14.27%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHS.CA Yearly Revenue VS EstimatesCHS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

Find the best growth stocksShow best growing peers

0

4. CHS.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • CHS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CHS.CA Price Earnings VS Forward Price EarningsCHS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CHS.CA Per share dataCHS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CHS.CA Dividend Analysis

5.1 Amount

  • CHS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CHS.CA Fundamentals: All Metrics, Ratios and Statistics

COMPREHENSIVE HEALTHCARE SYS

TSX-V:CHS (3/12/2026, 7:00:00 PM)

0.59

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.81%
Ins Owner ChangeN/A
Market Cap14.72M
Revenue(TTM)4.16M
Net Income(TTM)-1.13M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.58
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.23
BVpS-0.3
TBVpS-0.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -127.36%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.93%
FCFM N/A
ROA(3y)-235.23%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.64%
GM growth 5YN/A
F-Score5
Asset Turnover4.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2741.67%
Cap/Sales 4.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z -38.66
F-Score5
WACC9.23%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.73%
Revenue growth 3Y-5.71%
Revenue growth 5YN/A
Sales Q2Q%14.27%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y102.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y129.84%
OCF growth 3YN/A
OCF growth 5YN/A

COMPREHENSIVE HEALTHCARE SYS / CHS.CA Fundamental Analysis FAQ

What is the fundamental rating for CHS stock?

ChartMill assigns a fundamental rating of 0 / 10 to CHS.CA.


What is the valuation status of COMPREHENSIVE HEALTHCARE SYS (CHS.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to COMPREHENSIVE HEALTHCARE SYS (CHS.CA). This can be considered as Overvalued.


What is the profitability of CHS stock?

COMPREHENSIVE HEALTHCARE SYS (CHS.CA) has a profitability rating of 1 / 10.